Altamira Therapeutics Ltd. Other Current Liabilities
Altamira Therapeutics Ltd. (CYTOF) had Other Current Liabilities of CHF 929 as of 2023-12-31, per its 20-F/A filed 2024-04-22.
Financial Statements › Notes
ifrs-full:OtherCurrentLiabilities · last filed 2025-04-30
- 2023-12-31: Other Current Liabilities 929.00 CHF.
- 2022-12-31: Other Current Liabilities 42.78K CHF.
- 2021-12-31: Other Current Liabilities 63.59K CHF.
- 2020-12-31: Other Current Liabilities 9.46K CHF.
CHF
| Period end | Other Current Liabilities |
|---|---|
| 2023-12-31 | 929.00 CHF 20-F/A · filed 2024-04-22 |
| 2022-12-31 | 42.78K CHF 20-F/A · filed 2024-04-22 |
| 2021-12-31 | 63.59K CHF 20-F · filed 2023-05-16 |
| 2020-12-31 | 9.46K CHF 20-F · filed 2022-04-12 |
| 2019-12-31 | 140.45K CHF 20-F · filed 2021-03-31 |
| 2018-12-31 | 72.85K CHF 20-F · filed 2020-04-16 |
| 2017-12-31 | 108.20K CHF 20-F · filed 2019-03-14 |
| 2016-12-31 | 26.95K CHF 20-F · filed 2018-03-22 |
USD
| Period end | Other Current Liabilities |
|---|---|
| 2023-12-31 | $1.10K 20-F · filed 2025-04-30 |